朕天下娛樂城
Invest in 朕天下娛樂城
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
ADVENZYMES ?NSE
Advanced Enzyme Technologies
?371.00-2.40 (0.64%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
369.00
Today’s high
374.00
52 week low
251.95
52 week high
419.00
Open price
373.05
Previous close
373.40
Live volume
25,824
Lower circuit
298.75
Upper circuit
448.05
Fundamentals
Market Cap
?4,175Cr
ROE
10.34%
P/E Ratio(TTM)
24.05
EPS(TTM)
15.50
P/B Ratio
2.56
Dividend Yield
0.36%
Industry P/E
33.86
Book Value
145.74
Debt to Equity
0.02
Face Value
2
Financial performance
MAR '26
Revenue (Cr)
?211
+16.73%
Profit (Cr)
?45.25
+4.79%
062.5125187.5250
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +20% |
| 3Y CAGR | +8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +69% |
| 3Y CAGR | +3% |
About
Advanced Enzyme Technologies Limited is a research-driven company manufacturing enzymes and probiotics for human and animal healthcare.;
CEO/MD
NA
Founded in
1989
NSE symbol
ADVENZYMES
Shareholding Pattern
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Mutual Funds Invested (1)
| Fund name | AUM% |
|---|---|
| 0.10 |
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Suven Life SciencesSUVEN | ?268.85 +9.15 (3.52%) | 6,848.82 | -- | 11.58 | ||
Panacea BiotecPANACEABIO | ?548.75 +13.90 (2.60%) | 3,272.93 | -- | 3.92 | ||
CCME GlobalCCME | ?113.20 -0.05 (0.04%) | 512.46 | -- | 12.79 | ||
Transgene BiotekTRABI | ?3.00 -0.01 (0.33%) | 22.81 | -- | 2.72 |
Livesquawk ?
Advanced Enzymes plans FY27 growth, expanding human nutrition B2C in India via Wellfa.
It aims to scale animal nutrition sales teams in the USA, MENA, and Asia.
Livesquawk ?
Advanced Enzyme board recommends ?1.35 final dividend per equity share.
Livesquawk ?
Advanced Enzyme Q4 EBITDA rose to ?633M from ?457M YoY.
EBITDA margin expanded to 31.1% from 27.3% YoY.
2026
9
May
Quarterly & Annual Result
Release date
31
Jan
Quarterly Result
Release date
2025
12
Nov
Quarterly Result
Release date
2
Aug
Quarterly Result
Release date
23JulDividendEx date?1.20per share
23
Jul
Dividend
Ex date
?1.20
per share
For each share you hold, you will receive ?1.20
Dividend amount?1.20 per share
Dividend TypeFinal
Ex Date23 Jul ‘25
Record Date23 Jul ‘25
Announcement date13 May ‘25
16MayDividendEx date?4.00per share
16
May
Dividend
Ex date
?4.00
per share
For each share you hold, you will receive ?4.00
Dividend amount?4.00 per share
Dividend TypeInterim
Ex Date16 May ‘25
Record Date17 May ‘25
Announcement date13 May ‘25
13MayDividendAnnounced?1.20per share
13
May
Dividend
Announced
?1.20
per share
For each share you hold, you will receive ?1.20
Dividend amount?1.20 per share
Dividend TypeFinal
Ex Date23 Jul ‘25
Record Date23 Jul ‘25
Announcement date13 May ‘25
13MayDividendAnnounced?4.00per share
13
May
Dividend
Announced
?4.00
per share
For each share you hold, you will receive ?4.00
Dividend amount?4.00 per share
Dividend TypeInterim
Ex Date16 May ‘25
Record Date17 May ‘25
Announcement date13 May ‘25
2024
18JulDividendEx date?1.10per share
18
Jul
Dividend
Ex date
?1.10
per share
For each share you hold, you will receive ?1.10
Dividend amount?1.10 per share
Dividend TypeFinal
Ex Date18 Jul ‘24
Record Date18 Jul ‘24
Announcement date11 May ‘24
Events calendar
View upcoming events in other stocks